STOCK TITAN

Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Geron (Nasdaq: GERN) has announced its upcoming participation in the 7th Annual Evercore ISI HealthCONx Conference. The company's management team will engage in a fireside chat at the event, scheduled for December 4, 2024, at 8:20 a.m. ET in Coral Gables, Florida. A webcast of the presentation will be accessible through the Investors and Media section of Geron's website under Events and will remain available for replay for 30 days following the event.

Geron (Nasdaq: GERN) ha annunciato la sua partecipazione alla 7ª Conferenza Annuale Evercore ISI HealthCONx. Il team di gestione dell'azienda parteciperà a una chiacchierata informale durante l'evento, previsto per 4 dicembre 2024, alle 8:20 a.m. ET a Coral Gables, Florida. Una diretta streaming della presentazione sarà disponibile nella sezione Investitori e Media del sito web di Geron sotto Eventi e resterà accessibile per la visione in differita per 30 giorni dopo l'evento.

Geron (Nasdaq: GERN) ha anunciado su próxima participación en la 7ª Conferencia Anual Evercore ISI HealthCONx. El equipo directivo de la empresa participará en una charla informal en el evento, programado para el 4 de diciembre de 2024, a las 8:20 a.m. ET en Coral Gables, Florida. Una transmisión en vivo de la presentación estará disponible en la sección de Inversores y Medios del sitio web de Geron bajo Eventos y permanecerá accesible para su reproducción durante 30 días después del evento.

Geron (Nasdaq: GERN)제7회 연례 Evercore ISI HealthCONx 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사의 경영 팀은 2024년 12월 4일 오전 8시 20분 ET에 플로리다주 코럴 게이블스에서 열리는 행사에 참여하여 대담을 나눌 예정입니다. 발표의 웹캐스트는 Geron 웹사이트의 투자자 및 미디어 섹션의 이벤트에서 접근할 수 있으며, 행사 후 30일 동안 재생할 수 있습니다.

Geron (Nasdaq: GERN) a annoncé sa prochaine participation à la 7ème Conférence Annuelle Evercore ISI HealthCONx. L'équipe de direction de l'entreprise participera à une conversation informelle lors de l'événement, prévu pour le 4 décembre 2024 à 8h20 ET à Coral Gables, en Floride. Une diffusion en direct de la présentation sera accessible dans la section Investisseurs et Médias du site Web de Geron sous Événements et restera disponible en rediffusion pendant 30 jours après l'événement.

Geron (Nasdaq: GERN) hat seine bevorstehende Teilnahme an der 7. jährlichen Evercore ISI HealthCONx-Konferenz bekannt gegeben. Das Management-Team des Unternehmens wird an dem Event, das für 4. Dezember 2024 um 8:20 Uhr ET in Coral Gables, Florida, geplant ist, an einem informellen Gespräch teilnehmen. Ein Webcast der Präsentation wird im Bereich Investoren und Medien auf Gerons Webseite unter Veranstaltungen verfügbar sein und bleibt 30 Tage nach der Veranstaltung für eine Wiederholung zugänglich.

Positive
  • None.
Negative
  • None.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference, in Coral Gables, Florida on Wednesday, December 4, 2024, at 8:20 a.m. ET.

A webcast of the fireside chat will be available through the Investors and Media section of Geron’s website under Events following the presentation. The webcast will be archived and available for replay for a period of 30 days.

About Geron

Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO™ (imetelstat) is approved in the United States for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis (R/R MF), as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit www.geron.com or follow us on LinkedIn.

Aron Feingold

Vice President, Investor Relations and Corporate Communications

Kristen Kelleher

Associate Director, Investor Relations and Corporate Communications

investor@geron.com

media@geron.com

Source: Geron Corporation

FAQ

When is Geron (GERN) presenting at the Evercore ISI HealthCONx Conference 2024?

Geron (GERN) is scheduled to present at the Evercore ISI HealthCONx Conference on Wednesday, December 4, 2024, at 8:20 a.m. ET in Coral Gables, Florida.

How long will the GERN Evercore Conference webcast be available for replay?

The webcast of Geron's fireside chat will be archived and available for replay for 30 days following the presentation.

Where can I watch Geron's (GERN) Evercore Conference presentation?

The webcast can be accessed through the Investors and Media section of Geron's website under Events.

What type of presentation will GERN give at the 2024 Evercore Conference?

Geron's management team will participate in a fireside chat format presentation at the conference.

Geron Corp

NASDAQ:GERN

GERN Rankings

GERN Latest News

GERN Stock Data

1.75B
603.98M
0.09%
85.52%
12.19%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
FOSTER CITY